Newsroom
January 12, 2021
Dr. Monica Verduzco-Gutierrez, Rehabilitation Medicine, and Dr. Gabriel de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, were featured guests during Texas Public Radio’s “The Source” program to discuss what is known about the long-term and neurological effects of COVID-19. Listen to the interview.
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, was interviewed about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, was interviewed about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, was interviewed about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, contributed to this second KENS 5 TV news segment on the Novavax trial launch, emphasizing that minorities are desperately needed for clinical trials because the inclusion of diverse groups in trials is the only way to make effective vaccines for all. Read and watch the story.
January 12, 2021
UT Health San Antonio is providing vaccines for UT Health San Antonio patients who fall into the Tier 1b category as determined by the State of Texas and the Center for Disease Control and Prevention’s tiered prioritized COVID-19 vaccine distribution system. Eligible UT Health San Antonio patients will be contacted through MyChart or through phone to […]